In-vivo behavior of Si-hydroxyapatite/polycaprolactone/DMB scaffolds fabricated by 3D printing.

Scaffolds made of polycaprolactone and nanocrystalline silicon-substituted hydroxyapatite have been fabricated by 3D printing rapid prototyping technique. To asses that the scaffolds fulfill the requirements to be considered for bone grafting applications, they were implanted in New Zealand rabbits. Histological and radiological studies have demonstrated that the scaffolds implanted in bone exhibited an excellent osteointegration without the interposition of fibrous tissue between bone and implants and without immune response after 4 months of implantation. In addition, we have evaluated the possibility of improving the scaffolds efficiency by incorporating demineralized bone matrix during the preparation by 3D printing. When demineralized bone matrix (DBM) is incorporated, the efficacy of the scaffolds is enhanced, as new bone formation occurs not only in the peripheral portions of the scaffolds but also within its pores after 4 months of implantation. This enhanced performance can be explained in terms of the osteoinductive properties of the DBM in the scaffolds, which have been assessed through the new bone tissue formation when the scaffolds are ectopically implanted.

[1]  P. Revell,et al.  Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. , 2006, Biomaterials.

[2]  M. E. Gher,et al.  A comparison of polylactic acid granules and decalcified freeze-dried bone allograft in human periodontal osseous defects. , 1993, Journal of periodontology.

[3]  G. Daculsi,et al.  Biphasic calcium phosphate/hydrosoluble polymer composites: a new concept for bone and dental substitution biomaterials. , 1999, Bone.

[4]  M. Vallet‐Regí,et al.  Silicon incorporation in hydroxylapatite obtained by controlled crystallization , 2004 .

[5]  Larry L. Hench,et al.  An Introduction to Bioceramics , 2013 .

[6]  Marc A. Asher,et al.  Iliac Crest Bone Graft Harvest Donor Site Morbidity: A Statistical Evaluation , 1995, Spine.

[7]  M Bohner,et al.  Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. , 2000, Injury.

[8]  M. Vallet‐Regí,et al.  In vitro bioactivity of silicon-substituted hydroxyapatites. , 2003, Journal of biomedical materials research. Part A.

[9]  Dietmar W Hutmacher,et al.  Dynamics of in vitro polymer degradation of polycaprolactone-based scaffolds: accelerated versus simulated physiological conditions , 2008, Biomedical materials.

[10]  J N Skepper,et al.  Comparison of in vivo dissolution processes in hydroxyapatite and silicon-substituted hydroxyapatite bioceramics. , 2003, Biomaterials.

[11]  T. Buckland,et al.  Comparative performance of three ceramic bone graft substitutes. , 2007, The spine journal : official journal of the North American Spine Society.

[12]  C. Canal,et al.  Calcium phosphate cements as drug delivery materials. , 2012, Advanced drug delivery reviews.

[13]  Colleen L Flanagan,et al.  Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. , 2005, Biomaterials.

[14]  J O Hollinger,et al.  Biodegradable bone repair materials. Synthetic polymers and ceramics. , 1986, Clinical orthopaedics and related research.

[15]  M. Gebhardt,et al.  Infection in bone allografts. Incidence, nature, and treatment. , 1988, The Journal of bone and joint surgery. American volume.

[16]  B. Summers,et al.  Donor site pain from the ilium. A complication of lumbar spine fusion. , 1989, The Journal of bone and joint surgery. British volume.

[17]  Melba Navarro,et al.  New macroporous calcium phosphate glass ceramic for guided bone regeneration. , 2004, Biomaterials.

[18]  R. Giardino,et al.  Xenogenic demineralized bone matrix: osteoinduction and influence of associated skeletal defects in heterotopic bone formation in rats , 1999, International Orthopaedics.

[19]  M. Vallet‐Regí,et al.  Crystallochemistry, textural properties, and in vitro biocompatibility of different silicon-doped calcium phosphates. , 2006, Journal of biomedical materials research. Part A.

[20]  M. Vallet‐Regí,et al.  The effect of the silicon incorporation on the hydroxylapatite structure. A neutron diffraction study , 2004 .

[21]  Swee Hin Teoh,et al.  Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. , 2009, Journal of biomedical materials research. Part A.

[22]  Julian R. Jones,et al.  Protein interactions with nanoporous sol-gel derived bioactive glasses. , 2011, Acta biomaterialia.

[23]  N. Athanasou,et al.  The pathology of bone allograft. , 1999, The Journal of bone and joint surgery. British volume.

[24]  Banwart Jc,et al.  Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. , 1995 .

[25]  Beat Hammer,et al.  In vivo efficacy of bone-marrow-coated polycaprolactone scaffolds for the reconstruction of orbital defects in the pig. , 2003, Journal of biomedical materials research. Part B, Applied biomaterials.

[26]  L. Resnick,et al.  Human Immunodeficiency Virus Cultured From Bone: Implications for Transplantation , 1990, Clinical orthopaedics and related research.

[27]  N. Manolova,et al.  Hydrolytic degradation of poly(oxyethylene)–poly-(ε-caprolactone) multiblock copolymers , 1998 .

[28]  J. Lannutti,et al.  Effects of orthopedic implants with a polycaprolactone polymer coating containing bone morphogenetic protein-2 on osseointegration in bones of sheep. , 2009, American journal of veterinary research.

[29]  S. Holmberg,et al.  Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. , 1992, The New England journal of medicine.

[30]  Sergey V. Dorozhkin,et al.  Bioceramics of calcium orthophosphates. , 2010, Biomaterials.

[31]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[32]  M. Vallet‐Regí,et al.  Silicon substituted hydroxyapatites. A method to upgrade calcium phosphate based implants , 2005 .

[33]  W. Friess,et al.  Collagen sponges for bone regeneration with rhBMP-2. , 2003, Advanced drug delivery reviews.

[34]  M. Nimni,et al.  Effects of moisture and temperature on the osteoinductivity of demineralized bone matrix , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[35]  H. Chambers,et al.  Complications of iliac crest bone graft harvesting. , 1996, Clinical orthopaedics and related research.

[36]  K. P. Rao,et al.  Equilibrium swelling behavior of collagen‐poly(HEMA) copolymeric hydrogels , 1991 .

[37]  W. Bonfield,et al.  A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules , 2002, Journal of materials science. Materials in medicine.

[38]  Julian R. Jones,et al.  Tailoring the nanoporosity of sol–gel derived bioactive glass using trimethylethoxysilane , 2010 .

[39]  Michel Vert,et al.  Processing of polycaprolactone and polycaprolactone-based copolymers into 3D scaffolds, and their cellular responses. , 2009, Tissue engineering. Part A.

[40]  Minglong Yuan,et al.  Biodegradable and biocompatible nanocomposites of poly(∈-caprolactone) with hydroxyapatite nanocrystals: Thermal and mechanical properties , 2002 .

[41]  M. Vallet‐Regí,et al.  Immobilization and bioactivity evaluation of FGF-1 and FGF-2 on powdered silicon-doped hydroxyapatite and their scaffolds for bone tissue engineering , 2011, Journal of materials science. Materials in medicine.

[42]  T. Rosol,et al.  A comparison of bone turnover in athymic (nude) and euthymic mice: biochemical, histomorphometric, bone ash and in vitro studies. , 1989, Bone.

[43]  K Aitasalo,et al.  Reconstruction of orbital floor fractures using bioactive glass. , 2000, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[44]  W. Becker,et al.  Human demineralized freeze-dried bone: inadequate induced bone formation in athymic mice. A preliminary report. , 1995, Journal of periodontology.

[45]  C. Cornell,et al.  Osteoconductive materials and their role as substitutes for autogenous bone grafts. , 1999, The Orthopedic clinics of North America.

[46]  D. Orhan,et al.  In vitro and in vivo evaluation of the effects of demineralized bone matrix or calcium sulfate addition to polycaprolactone–bioglass composites , 2010, Journal of materials science. Materials in medicine.

[47]  D. W. Jackson,et al.  Intraarticular reaction associated with the use of freeze-dried, ethylene oxide-sterilized bone-patella tendon-bone allografts in the reconstruction of the anterior cruciate ligament , 1990, The American journal of sports medicine.

[48]  N. Ebraheim,et al.  Bone‐Graft Harvesting From Iliac and Fibular Donor Sites: Techniques and Complications , 2001, The Journal of the American Academy of Orthopaedic Surgeons.

[49]  D. Hutmacher,et al.  Scaffolds in tissue engineering bone and cartilage. , 2000, Biomaterials.

[50]  B. Boyan,et al.  Osteoinductivity of demineralized bone matrix in immunocompromised mice and rats is decreased by ovariectomy and restored by estrogen replacement. , 2007, Bone.

[51]  I. Zein,et al.  Fused deposition modeling of novel scaffold architectures for tissue engineering applications. , 2002, Biomaterials.

[52]  R. Holmes,et al.  Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. , 1989, Clinical orthopaedics and related research.

[53]  D. Kaplan,et al.  Porosity of 3D biomaterial scaffolds and osteogenesis. , 2005, Biomaterials.

[54]  G. Daculsi,et al.  Calcium phosphate scaffold and bone marrow for bone reconstruction in irradiated area: a dog study. , 2005, Bone.

[55]  S. Brocchini,et al.  Effect of glass composition on the degradation properties and ion release characteristics of phosphate glass--polycaprolactone composites. , 2005, Biomaterials.

[56]  R. Jinnah,et al.  The biology of bone grafting. , 1991, Orthopedics.

[57]  B. Boyan,et al.  Osteoinductivity of demineralized bone matrix is independent of donor bisphosphonate use. , 2011, The Journal of bone and joint surgery. American volume.

[58]  T Yamamuro,et al.  Apatite formation on the surface of Ceravital-type glass-ceramic in the body. , 1991, Journal of biomedical materials research.

[59]  J. Bromberg.  Implications for transplantation , 2012 .

[60]  G. Daculsi,et al.  Biphasic calcium phosphate: a comparative study of interconnected porosity in two ceramics. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.

[61]  W. Bonfield,et al.  Chemical characterization of silicon-substituted hydroxyapatite. , 1999, Journal of biomedical materials research.

[62]  S. Honsawek,et al.  Extractable bone morphogenetic protein and correlation with induced new bone formation in an in vivo assay in the athymic mouse model , 2005, Cell and Tissue Banking.

[63]  I Zein,et al.  Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. , 2001, Journal of biomedical materials research.

[64]  P. Supaphol,et al.  Polycaprolactone/hydroxyapatite composite scaffolds: preparation, characterization, and in vitro and in vivo biological responses of human primary bone cells. , 2010, Journal of biomedical materials research. Part A.